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Abstract 
Background. Anatomical considerations and risks related to x-ray exposure make atrio-
ventricular nodal reentrant tachycardia (AVNRT) ablation in pediatric patients a concerning 
procedure. We aimed to evaluate the feasibility, safety and efficacy of performing fluoroless 
slow pathway cryoablation guided by the electroanatomic (EA) mapping in children and 
adolescents. 
Methods. Twenty one consecutive patients (mean age 13.5±2.4 years) symptomatic for 
AVNRT were prospectively enrolled to right atrium EA mapping and electrophysiological 
study prior to cryoablation. Cryoablation was guided by slow-pathway potential and 
performed using a 4-mm tip catheter. 
Results. Sustained slow-fast AVNRT was inducible in all the patients with a dual AV nodal 
physiology in 95%. Acute success was achieved in 100% of the patients with a median of 2 
cryo-applications. Fluoroless ablation was feasible in 19 patients, while in 2 subjects 50 and 
45 seconds of x-ray were needed due to difficult progression of the catheters along the venous 
system. After a mean follow-up of 25 months AVNRT recurred in 5 patients. All the 
recurrences were successfully treated with a second procedure. In 3 patients a fluoroless 
cryoablation with a 6-mm tip catheter was successfully performed, while in the remaining 2 
patients a single pulse of 60 s of radiofrequency energy was applied under fluoroscopic 
monitoring. No complications occurred. 
Conclusions. Combination of EA mapping systems and cryoablation may allow to perform 
fluoroless slow-pathway ablation for AVNRT in children and adolescents in the majority of 
patients. Fluoroless slow-pathway cryoablation showed a high efficacy and safety comparable 
to conventional fluoroscopy guided procedures. 
Keywords: AVNRT; pediatric population; fluoroscopy; cryoablation; electroanatomic 
mapping. 
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Introduction 
Atrio-ventricular nodal reentrant tachycardia (AVNRT) is a common supraventricular 
arrhythmia in adults and children1-2. Catheter ablation in adulthood is a well-established 
treatment with a high success rate and a very low incidence of complications, the most 
dreadful to be the atrio-ventricular (AV) block (0.26%)2-4. This latter aspect has greater 
relevance especially in the pediatric population. In this subset of patients anatomic 
considerations such as a small triangle of Koch with the possible higher risk of AV node 
damage should be taken into account in AVNRT ablation5. Furthermore, the use of 
fluoroscopy exposes children to the potential harmful effects of radiations6-7. In fact, although 
AVNRT ablation is usually considered a low x-ray exposure procedure, literature reports 
fluoroscopy time ranging from 16 to 27 minutes8-9. For these reasons, many operators prefer 
to avoid or postpone ablation procedures to the end of childhood. 
Recently, it has been shown that non fluoroscopic electroanatomic (EA) mapping systems 
allows to reduce X-ray exposure for ablation procedures in children10-14. In addition, in few 
reports the feasibility of fluoroless procedures in children and adolescents has been 
demonstrated14-17, with a similar success and complication rate compared to conventional 
standard ablation procedures. 
Based on the above considerations, we decided to evaluate the feasibility, safety and 
effectiveness of performing fluoroless slow pathway cryoablation guided by EA mapping in 
children and adolescents at our institution. 
 
Methods 
Study group 
Twenty-one consecutive pediatric patients suffering from AVNRT were prospectively 
enrolled for the study. Every patient was highly symptomatic for palpitations. Before the 
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procedure a cardiac work up was carried out to evaluate the presence of an underlying 
structural heart disease. After written informed consent was obtained, all the patients 
underwent a diagnostic electrophysiological study under conscious sedation or narcosis. 
Electrophysiological Study 
Before ablation, every patient underwent a standard electrophysiological (EP) study. 
Two tetrapolar catheters and a decapolar steerable catheter were placed in His bundle region, 
right ventricular apex and coronary sinus respectively through a venous femoral approach. 
In accordance with operator desire CARTO3 or NavX EA system, providing multiple 
catheters’ visualization, were used to navigate the venous system and to perform a right 
atrium EA map in order to place all the catheters inside the heart minimizing the use of 
fluoroscopy. 
Ventricular and atrial stimulation protocols were used to assess conduction properties and 
arrhythmia inducibility. After the EP study was completed, slow pathway cryoablation was 
performed if AVNRT was inducible. 
Cardiac imaging integration 
NavX: the EnSite Velocity (St. Jude Medical, St. Paul, MN, USA) is a 3D cardiac mapping 
system that provides visualization and navigation of conventional electrophysiological 
catheters. This is a methodology based on the principle of applying an electrical current 
across 6 surface electrodes, evaluating the interaction of catheters with the electrical field. 
Thus, the system reproduces and shows catheters’ position reflecting their real-time motion 
and enables the creation of a 3D model of the cardiac chamber of interest. Using this system 
the cryoablation catheter may be connected and visualized also during the cryo-application. 
CARTO3: the new CARTO3 system (Biosense Webster, Diamond Bar, CA, USA) allows real 
time 3D reconstruction of the cardiac chambers and visualization of all of the catheters as in a 
standard fluoroscopic view. Once the EA mapping of the chamber considered is completed 
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using a Navistar (Biosense Webster, Diamond Bar, CA, USA) ablation catheter, all the other 
diagnostic catheters that enter this chamber could be visualized including the cryoablation 
catheter. In our population, the reconstruction of the right atrium (RA) was obtained by the 
FAM algorithm. This method continuously (non gated) records movements of the Navistar 
catheter. Based on this volume sampling, a surface reconstruction was built in accordance 
with the set resolution level. The geometric reconstruction of the RA started positioning the 
Navistar catheter on the superior vena cava. The mapping catheter was then withdrawn from 
the superior vena cava through the RA down to the inferior vena cava, touching the 
endocardial surface of the lateral, septal, anterior and posterior walls and tagging specific 
anatomic landmarks such as the His bundle, the tricuspid ring and the coronary sinus os. The 
navigation inside the chamber was guided by the integration of the direct visualization of the 
mapping catheter provided by the CARTO3 system and the analysis of the electrograms 
recorded from the tip of the roving catheter.  
With CARTO3, cryoenergy delivery interferes with the system and requires disconnection of 
the catheter before cryoenergy is turned on. Therefore, once the correct site is identified, it is 
necessary to disconnect the cryocatheter from the system, making the tip of the catheter not 
visualized. Few seconds are necessary to allow the adherence of the cryocatheter to the heart 
tissue. The lack of the visualization during these few seconds is counterbalanced by the fact 
that the effect created by the cryo-mapping is transient and reversible; then the repositioning 
of the catheter can be performed without any permanent unwanted consequences. Moreover, 
the lack of the visualization during the cryoenergy delivery does not affect the overall safety 
of the procedure because, after the first few seconds, the cryocatheter tip is adherent to the 
endocardial surface. 
Ablation Protocol 
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In our institution, slow pathway ablation in children is routinely performed using cryoenergy 
with a 4 mm-tip catheter in order to be more selective in the ablation lesion. Cryoablation 
with a 6 mm-tip catheter is performed in case of recurrences. If cryoablation fails, RF energy 
is used. 
The choice of the ablation site is guided by an electrophysiological and anatomic approach. 
Briefly, a 3D RA EA map is used to tag points of interest such as His bundle and slow 
pathway potential recording sites (Figure 1) to reproduce a detailed electroanatomy of the 
triangle of Koch. The target of ablation is the slow pathway potential recording18-19 as first 
choice. In case of inability to detect the abovementioned potential or ineffectiveness of 
previous ablation attempts, an anatomical approach is used20. Once the site is identified, cryo-
mapping is performed by cooling the tissue at a temperature of -30°C for a maximum of 60 
seconds. Since during cryoablation of slow pathway no junctional rhythm is generally 
observed, programmed stimulation is performed evaluating parameters such as the 
disappearance of dual AV nodal physiology, the modification of the slow pathway conduction 
with non-inducibility of the AVNRT or the interruption of the AVNRT itself. If one or more 
of these criteria are present without modification of the basal AV conduction, cryoablation is 
carried out lowering the temperature as far as -80°C for 8 min. 
In case of RF energy delivery, that implies a higher risk of AV block, the ablation catheter 
movements are monitored using fluoroscopy to immediately detect any catheter 
dislodgements. 
 
Results 
Study population 
Study population included 21 pediatric patients, 9 males and 12 females, with mean age of 
13.5 ± 2.4 years (range 7-16 years). All the patients had a normal heart but 2 patients: one 
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patient was affected by Shprintzen-Goldberg syndrome and the other one had left ventricular 
noncompaction. Mean cycle length during tachycardia was 300 ± 35 ms (range 422 – 250 
ms). Every patient was refractory to at least one antiarrhythmic drug. The median elapsed 
time from symptoms to ablation was 3.4 years (range 1-10 years) (Table 1). 
Procedural parameters and acute success 
At baseline, in all the patients a sustained slow-fast AVNRT was inducible; a dual AV nodal 
physiology was present in 20/21 (95%) patients. In 13 patients RA reconstruction was 
performed with the CARTO3 EA mapping system, whereas 8 cases were performed with the 
NavX. Cryo-application was guided by slow pathway potential recording in 18 patients (13 
postero-septal and 5 mid-septal sites). In the remaining 3 patients an anatomical approach was 
used due to the impossibility to detect the slow pathway potential. Acute success was 
achieved in all the 21 patients with a median of 2 cryo-applications. After the ablation only 
5/21 still showed an AV nodal jump. In one patient a transient lengthening of the AH interval 
after 1 minute of cryoablation at -80°C was observed, but normal AV conduction immediately 
recovered after the interruption of cryoenergy delivery. No transient or permanent AV block 
as well as any other complications were observed in the acute setting. Fluoroless procedure 
was possible in 19 out of 21 patients, while the remaining 2 patients required 50 and 45 
seconds of fluoroscopy respectively due to a difficult progression of the catheters along the 
venous system. Mean procedural time was 70 ± 20 minutes (range 55-120 minutes). Mean RA 
reconstruction time was 8 ± 3 minutes. Table 2 and 3 summarize procedural parameters in 
details. 
Long-term follow-up results 
No patient was lost at follow-up. At a mean follow-up of 25 months (range 6-86 months) 
AVNRT recurred in 5 patients. The mean elapsed time to recurrence was 61 days (range 1-
149 days). All these 5 patients were successfully treated with a second procedure, 3 using a 6-
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mm tip cryoablation catheter while 2 patients required RF energy to eliminate the slow 
pathway conduction because of a 6-mm tip cryoablation failure (Table 3). All the second 
cryoablation procedures were performed without fluoroscopy, while in the 2 patients who 
required RF delivery 60 seconds of X-ray were applied for each pulse in order to immediately 
detect any catheter dislodgement. 
No complications such as AV conduction disturbances occurred in the long-term follow-up in 
all the patients. No other recurrences were observed during the follow-up. 
 
Discussion 
This study reports the results of fluoroless slow-pathway cryoablation combined with the use 
of EA mapping systems in children and adolescents. The main results are as follows: 
- The use of EA mapping systems, by multiple catheters visualization, allowed no X-ray 
exposure in 22/24 (92%) cryoablation procedures, with a negligible fluoroscopic 
exposure (45 and 50 s) in 2 patients. 
- Fluoroless slow pathway cryoablation showed a high acute success rate (100%). In a 
small percentage of patients a second successful fluoroless cryoablation was 
necessary, reaching an overall efficacy of 92% (24/26 fluoroless procedures). In 2 
patients RF energy was used requiring fluoroscopy. 
- The fluoroless cryoablation of AVNRT in children and adolescents appeared to be 
safe since no acute or late complications occurred. 
Interventional procedures expose patients to a significant amount of radiation, with a not 
negligible risk of harmful effects and malignancies21. Children are inherently more 
susceptible to the risk of radiation induced carcinogenesis and therefore these concerns are 
even more relevant to the pediatric electrophysiologists6. In addition extensive fluoroscopy 
exposure causes significant health related problems also on medical staff22-23. In fact current 
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guidelines recommend all the physicians to minimize radiation injury hazard to patients, 
professional staff, and themselves24-25. Catheter ablation is an effective therapy for multiple 
arrhythmia substrates in children. Generally, this approach relies on the use of fluoroscopy. 
Although AVNRT ablation is usually considered a low X-ray exposure procedure, literature 
reports fluoroscopy time ranging from 16 to 27 minutes8-9. 
Several studies have demonstrated the feasibility of fluoroscopy reduction using non 
fluoroscopic mapping systems during ablation of supraventricular tachycardia10-14. Very few 
authors have focused on the complete elimination of fluoroscopy. To our knowledge, 4 
studies reported zero-fluoroscopy AVNRT ablation in children in the great majority of 
cases14-17. 
Our goal was to eliminate fluoroscopy in the slow pathway ablation procedure with the aid of 
EA mapping systems and the use of cryoenergy to obtain a high safety procedural profile. In 
our pediatric population fluoroless cryoablation was feasible in the 92% of the procedures. 
Minimal fluoroscopy time was used in 2 patients only to manage difficult progression of the 
catheters along the venous system and in 2 cases to monitor RF delivery. 
In our patient population either NavX or CARTO3 were used as electroanatomic mapping 
systems. In the literature, the non fluoroscopic EA mapping system most widely used is the 
NavX since it allows the real time visualization of all the catheters including the cryocatheter. 
No reports were found about the use of the CARTO3 system combined with cryoenergy since 
cryoenergy delivering interferes with the system. It is important to note that, in our 
experience, cryoablation with CARTO3 was feasible. This result was possible disconnecting 
the ablation catheter during the cryo-application. Few seconds are necessary to allow the 
adherence of the cryocatheter to the heart tissue. The lack of the visualization during these 
few seconds may be counterbalanced by the fact that the effect created by the cryo-mapping is 
transient and reversible. Then, the repositioning of the catheter can be performed without any 
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permanent unwanted consequences in case of ineffective positioning. After few seconds, the 
tip of the catheter is stuck to the endocardial surface and its adherence to the tissue allows to 
carry out the ablation procedure without the need of real time catheter visualization. On the 
other side, the CARTO3 system has the disadvantage of requiring a dedicated catheter for 
mapping and another catheter for cryoablation, making the procedure more expensive. After 
this preliminary experience, in our laboratory, the protocol of AVNRT ablation in children 
employing the CARTO3 system has been changed. In order to reduce the procedural costs, a 
Navistar catheter to perform the mapping and to pace from the atrium or from the ventricle is 
used once the right atrium mapping is completed. In such a way, the use of a diagnostic 
ventricular or atrial catheter can be avoided, reducing the cost of the procedure. Nevertheless, 
in our experience, the use of NavX or CARTO 3 system showed comparable clinical results. 
Literature reports acute success of AVNRT cryoablation in children ranging from 75% to 
100% with a recurrence rate up to 27%8,26-31. In our population acute success rate was 100% 
without complications. A precise 3D EA reconstruction of the RA may explain this high 
success rate. In fact, the detailed location of Koch’s triangle combined with the use of slow 
pathway potential as a target allowed us to tailor the ablation upon specific patient’s anatomy. 
In addition, we deem that the use of cryoenergy is justified by the lower incidence of AV 
block compared to AVNRT RF ablation in pediatric population4-5,32-34, even if a higher 
recurrence rate is reported. It can be speculated that the detailed 3D EA reconstruction of 
Koch’s triangle combined with the use of cryoenergy may account for the absence of any 
acute and long-term complications in our study population. 
The overall long-term success rate using fluoroless cryoablation was 92% (24/26 procedures), 
similar to the success rate for RF ablation33-36. However, this result has been achieved 
performing a second fluoroless cryoablation procedure in 3 patients. 
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Our recurrence rate with the use of cryoenergy may relate to the use of the 4 mm-tip 
cryocatheter. Our choice was determined by idea to be as safe as possible in order to avoid 
large lesions in pediatric patients. The results from the literature are conflicting about the use 
of 4 mm versus 6 mm-tip catheter. In fact, a recent paper by Reents et al37 reports that the use 
of 4 mm versus 6 mm-tip catheter is not predictive for recurrences. On the other side, Rivard 
et al38 reports a 2.5 fold increased risk of recurrences with the use of the 4 mm-tip 
cryocatheter. Chanani et al39 observe a lower recurrence rate with the use of the 6 mm-tip 
catheter without reaching a statistical significance. Based on the results seen in our study, 
probably we may use a 6 mm-tip cryocatheter as a first choice in this cohort of patients.  
 
In conclusion the present paper confirms that EA mapping guided cryoablation of AVNRT in 
children and adolescents may be performed without fluoroscopy in the great majority of 
patients. Fluoroless slow-pathway cryoablation showed a high efficacy and safety comparable 
to conventional fluoroscopy guided procedures. The consequent reduction or elimination of 
exposure to ionizing radiation is likely to be highly valued, especially in children. 
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Table 1. Study population. 
PT AGE SEX WEIGHT (Kg) STRUCTURAL HEART DISEASE 
AVNRT CYCLE 
LENGTH (msec) 
ANTIARRHYTHMIC 
DRUGS 
1 14 M 45 Shprintzen-Goldberg Syndrome 250 b-blocker, flecainide 
2 13 F 43  
 
422 Ca2+antagonist 
3 13 F 46  272 b-blocker, flecainide 
4 15 M 50  
 
300 b-blocker 
5 16 M 52 Left ventricular noncompaction 300 
b-blocker, amiodarone, 
Ca2+antagonist, propafenone, 
flecainide 
6 14 F 46  
 
300 b-blocker 
7 14 M 75  
 
333 Ca2+antagonist 
8 14 F 48  
 
285 b-blocker 
9 12 M 40  
 
292 b-blocker 
10 16 F 55  
 
315 b-blocker 
11 15 F 49  
 
300 propafenone 
12 16 F 61  
 
260 flecainide 
13 16 F 56  
 
292 Ca2+antagonist 
14 13 F 65  
 
300 Ca2+antagonist 
15 15 F 53  
 
317 b-blocker 
16 10 F 35  300 Ca2+antagonist, preopafenone, digoxin 
17 15 M 53  
 
300 b-blocker 
18 12 M 72  272 b-blocker 
19 13 M 42  300 b-blocker 
20 7 F 32  
 
300 b-blocker 
21 13 M 45  
 
260 Ca2+antagonist 
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Table 2. Procedural parameters. 
PT PROCEDURAL TIME (min) 
ELECTROANATOMIC 
MAPPING SYSTEM 
DUAL AV NODAL 
PHYSIOLOGY 
BEFORE 
ABLATION 
TARGET N°/TIME OF APPLICATIONS 
DUAL AV NODAL 
PHYSIOLOGY 
AFTER ABLATION 
FLUOROSCOPY 
TIME (sec) 
1 60 CARTO3 Yes A (Post-s.) 1/8 min No 0 
2 45 CARTO3 Yes S (Post-s.) 1/8 min Yes 0 
3 45 NavX Yes S (Post-s.) 2/16 min Yes 0 
4 65 CARTO3 No S (Mid-s.) 2/16 min No 0 
5 60 NavX Yes A (Mid-s.) 3/24 min No 45 
6 75 NavX Yes S (Post-s.) 2/16 min No 0 
7 75 NavX Yes S (Mid-s.) 3/24 min Yes 0 
8 90 CARTO3 Yes S (Post-s.) 2/16 min No 0 
9 110 CARTO3 Yes S (Post-s.) 2/16 min No 0 
10 60 CARTO3 Yes A (Mid-s.) 2/16 min No 50 
11 75 NavX Yes S (Post-s.) 1/8 min No 0 
12 60 CARTO3 Yes S (Post-s.) 2/16 min No 0 
13 65 CARTO3 Yes S (Post-s.) 1/8 min No 0 
14 55 NavX Yes S (Mid-s.) 2/16 min Yes 0 
15 90 CARTO3 Yes S (Mid-s.) 1/8 min No 0 
16 120 CARTO3 Yes S (Post-s.) 3/24 min No 0 
17 60 NavX Yes S (Post-s.) 2/16 min No 0 
18 60 NavX Yes S (Post-s) 1/8 min No 0 
19 60 CARTO3 Yes S (Post-s) 2/8 min No 0 
20 70 CARTO3 Yes S (Post-s) 2/8 min No 0 
21 60 CARTO3 Yes S (Mid-s) 4/32 min Yes 0 
 
A=Anatomical; S=Slow potential; Post-s.=Postero-septal; Mid-s.=Mid-septal 
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Table 3. Redo procedures. 
PT PROCEDURAL TIME (min) 
DUAL AV 
NODAL 
PHYSIOLOGY 
BEFORE 
ABLATION 
TARGET N°/TIME OF APPLICATIONS 
DUAL AV 
NODAL 
PHYSIOLOGY 
AFTER 
ABLATION 
FLUOROSCOPY 
TIME (sec) 
1 90 Yes A (Post-s.) 3/24 min Yes 0 
3 110 Yes S (Post-s.) 2/16 min No 0 
5 140 Yes A (Mid-s.) RF No 60 
7 105 No S (Mid-s.) 3/24 min No 0 
13 75 Yes S (Post-s.) RF No 60 
 
 
A=Anatomical; S=Slow potential; Post-s.=Postero-septal; Mid-s.=Mid-septal; 
RF=radiofrequency. 
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Figure 1. 3-D reconstruction of the right atrium using CARTO3 and NavX mapping 
systems. 
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Figure legend: 
Panels A, B and C: CARTO3 right atrium reconstruction. 
Panels D, E and F: NavX right atrium reconstruction. 
Panels A and D: Left Anterior Oblique view; Panels B and E: Left Lateral view; Panels C and 
F: Right Lateral view with a cutting plane allowing the visualization of the interatrial septum 
and the triangle of Koch. 
In every Panel (A, B, C, D, E, F) it is shown a tetrapolar catheter in the His bundle region and 
in the right ventricle, a multipolar catheter in the coronary sinus and the cryoablation catheter 
(indicated by a white arrow) in the triangle of Koch. 
Tag points of interest in the triangle of Koch. 1:  His bundle recording in the anteroseptal area 
of the tricuspid annulus; 2: site with the smallest His bundle potential recording; 3: slow 
pathway potential recording.  
Panels G and I: endocavitary recordings from the tag points of interest in the triangle of Koch. 
(A: atrial electrogram; V: ventricular electrogram; H: His bundle potential; black arrow 
indicates slow pathway potential). 
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